These data and our model are distinctly different from data and conclusions generated in rodents, in which IL-17 was shown to favor in vivo collagen deposition in models of bleomycin-induced skin as well as lung fibrosis [29,30,40]. The gene discussed is IL17A; the disease is pulmonary fibrosis.